Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study

Author:

Charleer Sara1ORCID,De Block Christophe2,Nobels Frank3,Radermecker Régis P.4,Lowyck Ine5,Mullens Annelies6,Scarnière Denis7,Spincemaille Katrien8,Strivay Marie9,Weber Eric10,Taes Youri11,Vercammen Chris12,Keymeulen Bart13,Mathieu Chantal1ORCID,Gillard Pieter1ORCID

Affiliation:

1. Department of Endocrinology, University Hospitals Leuven–KU Leuven, Leuven, Belgium

2. Department of Endocrinology, Diabetology and Metabolism, University of Antwerp–Antwerp University Hospital, Antwerp, Belgium

3. Department of Endocrinology, OLV Hospital Aalst, Aalst, Belgium

4. Department of Diabetes, Nutrition and Metabolic Disorders, CHU Liege–Liege University, Liege, Belgium

5. Department of Endocrinology, Ziekenhuis Oost-Limburg, Genk, Belgium

6. Department of Endocrinology, Jessa Ziekenhuis, Hasselt, Belgium

7. Department of Endocrinology-Diabetology, Grand Hôpital de Charleroi, Gilly, Belgium

8. Department of Endocrinology, AZ Delta, Roeselare, Belgium

9. Department of Endocrinology, CHR La Citadelle Liège, Liege, Belgium

10. Department of Endocrinology, Cliniques du Sud Luxembourg–Vivalia, Arlon, Belgium

11. Department of Endocrinology, AZ Sint-Jan Brugge AV, Bruges, Belgium

12. Department of Endocrinology, Imelda Hospital Bonheiden, Bonheiden, Belgium

13. Diabetes clinic, University Hospital Brussels–VUB, Brussels, Belgium

Abstract

OBJECTIVE In recent years, a growing number of people with type 1 diabetes gained access to real-time continuous glucose monitoring (rtCGM). Long-term benefits of rtCGM are unclear because of a lack of large studies of long duration. We evaluated whether real-world rtCGM use up to 24 months offered benefits, particularly in those living with impaired awareness of hypoglycemia (IAH). RESEARCH DESIGN AND METHODS This 24-month, prospective, observational cohort study followed 441 adults with insulin pumps receiving full reimbursement for rtCGM. Forty-two percent had IAH. The primary end point was evolution of HbA1c, with secondary end points change in acute hypoglycemia complications, diabetes-related work absenteeism, and quality of life scores. Additionally, we evaluated whether people could achieve glycemic consensus targets during follow-up. RESULTS After 24 months, HbA1c remained significantly lower compared with baseline (7.64% [60 mmol/mol] vs. 7.37% [57 mmol/mol], P < 0.0001). Sustained benefits were also observed for the score on the hypoglycemia fear survey and hypoglycemia-related acute complications irrespective of hypoglycemia awareness level. People with IAH had the strongest improvement, especially for severe hypoglycemia (862 events in the year before vs. 119 events per 100 patient-years in the 2nd year, P < 0.0001). Over 24 months, more people were able to meet hypoglycemia consensus targets at the expense of slightly fewer people achieving hyperglycemia consensus targets. Furthermore, the number of people with HbA1c <7% (<53 mmol/mol) without severe hypoglycemia events more than doubled (11.0% vs. 25.4%, P < 0.0001). CONCLUSIONS Use of rtCGM led to sustained improvements in hypoglycemia-related glucose control over 24 months. Lower fear of hypoglycemia, fewer acute hypoglycemia-related events, and fewer diabetes-related days off from work were observed, particularly in those with IAH.

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3